Antimicrobial host defensins specific antibiotic activities and innate defense modulation

Frontiers in Immunology

Volumn 3, Issue AUG, 2012, Pages

  Ulm, Hannah ^a   Wilmes, Miriam ^a   Shai, Yechiel ^b   Sahl, Hans Georg ^a  

^a UNIVERSITY OF BONN   (Germany)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874199991     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00249     Document Type: Article

References (48)

1. Andes, D., Craig, W., Nielsen, L. A., and Kristensen, H. H. (2009). In vivo pharmacodynamic characterization of a novel plectasin antibiotic, NZ2114, in a murine infection model. Antimicrob. Agents Chemother. 53, 3003-3009.
2. Barlow, P. G., Li, Y. X., Wilkinson, T. S., Bowdish, D. M., Lau, Y. E., Cosseau, C., Haslett, C., Simpson, A. J., Hancock, R. E., and Davidson, D. J. (2006). The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. J. Leukoc. Biol. 80, 509-520.
3. Brown, K. L., and Hancock, R. E. (2006). Cationic host defense (antimicrobial) peptides. Curr. Opin. Immunol. 18, 24-30.
4. Choi, K. Y., Chow, L. N., and Mookherjee, N. (2012). Cationic host defence peptides: multifaceted role in immune modulation and inflammation. J. Innate Immun. 4, 361-370.
5. de Leeuw, E., Li, C. Q., Zeng, P. Y., Li, C., Diepeveen-de Buin, M., Lu, W. Y., Breukink, E., and Lu, W. Y. (2010). Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II. FEBS Lett. 584, 1543-1548.
6. Easton, D. M., Nijnik, A., Mayer, M. L., and Hancock, R. E. (2009). Potential of immunomodulatory host defense peptides as novel anti-infectives. Trends Biotechnol. 27, 582-590.
7. Falagas, M. E., and Kasiakou, S. K. (2006). Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit. Care 10, R27.
8. Funderburg, N., Lederman, M. M., Feng, Z., Drage, M. G., Jacllowsky, J., Harding, C. V., Weinberg, A., and Sieg, S. F. (2007). Human beta-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc. Natl. Acad. Sci. U.S.A. 104, 18631-18635.
9. Ganz, T. (2003). Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3, 710-720.
10. Hancock, R. E., and Lehrer, R. (1998). Cationic peptides: a new source of antibiotics. Trends Biotechnol. 16, 82-88.
11. Hancock, R. E., and Sahl, H. G. (2006). Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24, 1551-1557.
12. Hirsch, T., Spielmann, M., Zuhaili, B., Fossum, M., Metzig, M., Koehler, T., Steinau, H. U., Yao, F., Onderdonk, A. B., Steinstraesser, L., and Eriksson, E. (2009). Human beta-defensin-3 promotes wound heating in infected diabetic wounds. J. Gene Med. 11, 220-228.
13. Kesting, M. R., Loeffelbein, D. J., Hasler, R. J., Wolff, K. D., Rittig, A., Schulte, M., Hirsch, T., Wagenpfeil, S., Jacobsen, F., and Steinstraesser, L. (2009). Expression profile of human beta-defensin 3 in oral squamous cell carcinoma. Cancer Invest. 27, 575-581.
14. Kraus, D., Deschner, J., Jäger, A., Wenghoefer, M., Bayer, S., Jepsen, S., Allam, J. P., Novak, N., Meyer, R., and Winter, J. (2012). Human ss-defensins differently affect proliferation, differentiation, and mineralization of osteoblast-like MG63 cells. J. Cell. Physiol. 227, 994-1003.
15. Lehrer, R. I. (2004). Primate defensins. Nat. Rev. Microbiol. 2, 727-738.
16. Lipsky, B. A., Holroyd, K. J., and Zasloff, M. (2008). Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. Clin. Infect. Dis. 47, 1537-1545.
17. Maemoto, A., Qu, X. Q., Rosengren, K. J., Tanabe, H., Henschen-Edman, A., Craik, D. J., and Ouellette, A. J. (2004). Functional analysis of the alpha-defensin disulfide array in mouse cryptdin-4. J. Biol. Chem. 279, 44188-44196.
18. McDermott, A. M. (2004). Defensins and other antimicrobial peptides at the ocular surface. Ocul. Surf. 2, 229-247.
19. McPhee, J. B., Scott, M. G., and Hancock, R. E. (2005). Design of host defence peptides for antimicrobial and immunity enhancing activities. Comb. Chem. High Throughput Screen. 8, 257-272.
20. Mookherjee, N., Brown, K. L., Bowdish, D. M., Doria, S., Falsafi, R., Hokamp, K., Roche, F. M., Mu, R. X., Doho, G. H., Pistolic, J., Powers, J. P., Bryan, J., Brinkman, F. S., and Hancock, R. E. (2006). Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J. Immunol. 176, 2455-2464.
21. Nijnik, A., Madera, L., Ma, S. H., Waldbrook, M., Elliott, M. R., Easton, D. M., Mayer, M. L., Mullaly, S. C., Kindrachuk, J., Jenssen, H., and Hancock, R. E. (2010). Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment. J. Immunol. 184, 2539-2550.
22. Niyonsaba, F., Iwabuchi, K., Matsuda, H., Ogawa, H., and Nagaoka, I. (2002). Epithelial cell-derived human beta-defensin-2 acts as a chemotaxin for mast cells through a pertussis toxin-sensitive and phospholipase C-dependent pathway. Int. Immunol. 14, 421-426.
23. Niyonsaba, F., Someya, A., Hirata, M., Ogawa, H., and Nagaoka, I. (2001). Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D-2 production from mast cells. Eur. J. Immunol. 31, 1066-1075.
24. Niyonsaba, F., Ushio, H., Nakano, N., Ng, W., Sayama, K., Hashimoto, K., Nagaoka, I., Okumura, K., and Ogawa, H. (2007). Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J. Invest. Dermatol. 127, 594-604.
25. Oren, Z., Hong, J., and Shai, Y. (1997). A repertoire of novel antibacterial diastereomeric peptides with selective cytolytic activity. J. Biol. Chem. 272, 14643-14649.
26. Sandgren, S., Wittrup, A., Cheng, F., Jonsson, M., Eklund, E., Busch, S., and Belting, M. (2004). The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. J. Biol. Chem. 279, 17951-17956.
27. Sass, V., Pag, U., Tossi, A., Bierbaum, G., and Sahl, H. G. (2008). Mode of action of human beta-defensin 3 against Staphylococcus aureus and transcriptional analysis of responses to defensin challenge. Int. J. Med. Microbiol. 298, 619-633.
28. Sass, V., Schneider, T., Wilmes, M., Körner, C., Tossi, A., Novikova, N., Shamova, O., and Sahl, H. G. (2010). Human beta-defensin 3 inhibits cell wall biosynthesis in staphylococci. Infect. Immun. 78, 2793-2800.
29. Schmitt, P., Wilmes, M., Pugniere, M., Aumelas, A., Bachere, E., Sahl, H. G., Schneider, T., and Destoumieux-Garzon, D. (2010). Insight into invertebrate defensin mechanism of action: oyster defensins inhibit peptidoglycan biosynthesis by binding to lipid II. J. Biol. Chem. 285, 29208-29216.
30. Schneider, J. J., Unholzer, A., Schaller, M., Schäfer-Korting, M., and Korting, H. C. (2005). Human defensins. J. Mol. Med. 83, 587-595.
31. Schneider, T., Kruse, T., Wimmer, R., Wiedemann, I., Sass, V., Pag, U., Jansen, A., Nielsen, A. K., Mygind, P. H., Ravents, D. S., Neve, S., Ravn, B., Bonvin, A. M., De Maria, L., Andersen, A. S., Gammelgaard, L. K., Sahl, H. G., and Kristensen, H. H. (2010). Plectasin, a fungal defensin, targets the bacterial cell wall precursor lipid II. Science 328, 1168-1172.
32. Scott, M. G., Davidson, D. J., Gold, M. R., Bowdish, D., and Hancock, R. E. (2002). The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 169, 3883-3891.
33. Scott, M. G., Dullaghan, E., Mookherjee, N., Glavas, N., Waldbrook, M., Thompson, A., Wang, A. K., Lee, K., Doria, S., Hamill, P., Yu, J. J., Li, Y. X., Donini, O., Guarna, M. M., Finlay, B. B., North, J. R., and Hancock, R. E. (2007). An anti-infective peptide that selectively modulates the innate immune response. Nat. Biotechnol. 25, 465-472.
34. Shai, Y. (2002). Mode of action of membrane active antimicrobial peptides. Biopolymers 66, 236-248.
35. Soehnlein, O., Kai-Larsen, Y., Frithiof, R., Sorensen, O. E., Kenne, E., Scharffetter-Kochanek, K., Eriksson, E. E., Herwald, H., Agerberth, B., and Lindbom, L. (2008). Neutrophil primary granule proteins HBP and HNP1-3 boost bacterial phagocytosis by human and murine macrophages. J. Clin. Invest. 118, 3491-3502.
36. Tauber, S. C., and Nau, R. (2008). Immunomodulatory properties of antibiotics. Curr. Mol. Pharmacol. 1, 68-79.
37. Thevissen, K., Francois, I. E., Takemoto, J. Y., Ferket, K. K., Meert, E. M., and Cammue, B. P. (2003). DmAMP1, an antifungal plant defensin from dahlia (Dahlia merckii), interacts with sphingolipids from Saccharomyces cerevisiae. FEMS Microbiol. Lett. 226, 169-173.
38. Thevissen, K., Ghazi, A., De Samblanx, G. W., Brownlee, C., Osborn, R. W., and Broekaert, W. F. (1996). Fungal membrane responses induced by plant defensins and thionins. J. Biol. Chem. 271, 15018-15025.
39. Thevissen, K., Tavares, P. D., Xu, D. M., Blankenship, J., Vandenbosch, D., Idkowiak-Baldys, J., Govaert, G., Bink, A., Rozental, S., de Groot, P. W., Davis, T. R., Kumamoto, C. A., Vargas, G., Nimrichter, L., Coenye, T., Mitchell, A., Roemer, T., Hannun, Y. A., and Cammue, B. P. (2012). The plant defensin RsAFP2 induces cell wall stress, septin mislocalization and accumulation of ceramides in Candida albicans. Mol. Microbiol. 84, 166-180.
40. Travis, S., Yap, L. M., Hawkey, C., Warren, B., Lazarov, M., Fong, T., and Tesi, R. J. (2005). RDP58 is a novel and potentially effective oral therapy for ulcerative colitis. Inflamm. Bowel Dis. 11, 713-719.
41. Trotti, A., Garden, A., Warde, P., Symonds, P., Langer, C., Redman, R., Pajak, T. F., Fleming, T. R., Henke, M., Bourhis, J., Rosenthal, D. I., Junor, E., Cmelak, A., Sheehan, F., Pulliam, J., Devitt-Risse, P., Fuchs, H., Chambers, M., O'Sullivan, B., and Ang, K. K. (2004). A multinational, randomized phase III trial of iseganan HCL oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy. Int. J. Radiat. Oncol. Biol. Phys. 58, 674-681.
42. Turner-Brannen, E., Choi, K. Y., Lippert, D. N., Cortens, J. P., Hancock, R. E., El Gabalawy, H., and Mookherjee, N. (2011). Modulation of interleukin-1 beta-induced inflammatory responses by a synthetic cationic innate defence regulator peptide, IDR-1002, in synovial fibroblasts. Arthritis Res. Ther. 13, R129.
43. Wieczorek, M., Jenssen, H., Kindrachuk, J., Scott, W. R., Elliott, M., Hilpert, K., Cheng, J. T., Hancock, R. E., and Straus, S. K. (2010). Structural studies of a peptide with immune modulating and direct antimicrobial activity. Chem. Biol. 17, 970-980.
44. Wu, Z. B., Hoover, D. M., Yang, D., Boulegue, C., Santamaria, F., Oppenheim, J. J., Lubkowski, J., and Lu, W. Y. (2003). Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc. Natl. Acad. Sci. U.S.A. 100, 8880-8885.
45. Yang, D., Chen, Q., Chertov, O., and Oppenheim, J. J. (2000). Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J. Leukoc. Biol. 68, 9-14.
46. Yeung, A. T., Gellatly, S. L., and Hancock, R. E. (2011). Multifunctional cationic host defence peptides and their clinical applications. Cell. Mol. Life Sci. 68, 2161-2176.
47. Zasloff, M. (2002). Antimicrobial peptides of multicellular organisms. Nature 415, 389-395.
48. Zhang, L. J., Parente, J., Harris, S. A., Woods, D. E., Hancock, R. E., and Fallal, T. J. (2005). Antimicrobial peptide therapeutics for cystic fibrosis. Antimicrob. Agents Chemother. 49, 2921-2927